This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Enteral Nutrition Protocols

Enteral nutrition protocols use oral nutrition supplements or feeding tubes into the stomach or small intestine to maintain calories, protein, hydration, and treatment tolerance when cancer or cancer therapy makes ordinary eating inadequate. Overview Enteral nutrition is nutrition delivered through the gastrointestinal tract when a person cannot safely or adequately meet nutrition needs by ordinary eating.

Description

Overview

Enteral nutrition is nutrition delivered through the gastrointestinal tract when a person cannot safely or adequately meet nutrition needs by ordinary eating. In cancer care this may include oral nutrition supplements, liquid formulas through a nasogastric tube, gastrostomy tube, gastrojejunostomy tube, or jejunostomy tube, and home tube feeding after hospital discharge. It is different from parenteral nutrition, which bypasses the gut and delivers nutrients into the bloodstream.

Enteral nutrition is not a cancer-killing treatment. It is a supportive-care protocol used to protect weight, muscle, hydration, treatment tolerance, wound healing, and quality of life when cancer or cancer treatment makes eating difficult. The guiding principle is usually “use the gut if the gut works,” while adapting the route, formula, schedule, and monitoring to the patient’s cancer type, swallowing function, digestion, aspiration risk, goals of care, and expected duration of need.

How it connects to cancer

Many cancers and treatments interfere with eating. Head and neck cancers, esophageal cancer, stomach cancer, pancreatic cancer, colorectal cancer, lung cancer, liver cancer, advanced abdominal disease, and hematologic cancers can all create situations where intake drops below need. Surgery, radiation, chemotherapy, immunotherapy side effects, mucositis, dysphagia, taste changes, nausea, vomiting, bowel obstruction, gastroparesis, diarrhea, pain, fatigue, and cachexia can make ordinary meals unrealistic.

When oral intake is not enough and the gastrointestinal tract can still absorb nutrients, enteral nutrition may help prevent or treat malnutrition. It may be short term, such as an NG or NJ tube during intensive chemoradiation, or longer term, such as PEG, G-tube, GJ-tube, or J-tube feeding after major head and neck, esophageal, gastric, or pancreatic surgery. Some patients use tube feeding as their main nutrition source; others use it to supplement what they can still eat by mouth.

Common approaches

Enteral protocols usually begin with nutrition screening and a dietitian-led assessment of weight loss, intake, muscle loss, inflammation, swallowing, digestive function, hydration, electrolytes, bowel function, medications, food safety, and home support. Formula selection may involve standard polymeric formulas, high-calorie formulas, high-protein formulas, fiber-containing formulas, peptide-based formulas, disease-specific formulas, or carefully planned blenderized tube feeding. Feeding schedules may be bolus, gravity, intermittent, or pump-controlled continuous feeding.

Access decisions depend on duration and anatomy. Nasogastric or nasojejunal tubes are often used for shorter-term needs. Gastrostomy or jejunostomy tubes are considered when longer support is expected. Postpyloric or jejunal feeding may be considered when gastric feeding is poorly tolerated or aspiration risk is high. In palliative settings, the decision becomes more individualized and should account for comfort, patient goals, expected benefit, burden, and prognosis.

Safety and monitoring

Enteral nutrition can be highly useful, but it requires careful monitoring. Practical risks include aspiration, tube displacement, clogging, leakage, site infection, diarrhea, constipation, nausea, vomiting, dehydration, electrolyte abnormalities, formula intolerance, medication interactions, and refeeding syndrome in severely malnourished patients. Tube placement, flushing, formula handling, pump settings, head-of-bed elevation, and medication administration through tubes all matter.

Patients should be taught how to recognize warning signs such as fever, tube-site redness, unexpected pain, persistent vomiting, inability to flush the tube, sudden breathing symptoms during feeding, or rapid weight change. A cancer patient receiving enteral nutrition should usually have coordinated follow-up with oncology, nutrition, nursing, speech-language pathology when swallowing is involved, gastroenterology or interventional radiology for tube issues, and home-infusion or durable medical equipment teams when feeding occurs at home.

Patient use and reported experiences

Patients often describe feeding tubes with mixed emotions. Some initially resist them, then later report relief because nutrition becomes possible during painful swallowing, severe appetite loss, or postoperative recovery. Others find the tube burdensome, uncomfortable, socially difficult, or frustrating because of formula intolerance or equipment logistics. The most useful patient reports identify the cancer type, tube type, formula, feeding schedule, side effects, and whether the tube was preventive, reactive, temporary, or long-term.

All Protocols